24 results
Thumbnail

D3.243 - Food allergy in children with inherited epidermolysis bullosa: possible role of transcutaneous sensitization and features of the clinical course

Thumbnail

D3.240 - Differential microRNA expression in chronic spontaneous urticaria in relation to treatment response

Thumbnail

D3.241 - How Clinical Control of Chronic Urticaria influence in mental health

Thumbnail

D3.242 - SDRIFE induced by multiple systemic corticosteroids

Thumbnail

D3.244 - STK4 Deficiency Presenting with Epidermodysplasia Verruciformis

Thumbnail

D3.245 - Complete Resolution of Systemic Delayed Hypersensitivity following Removal of a Titanium Fixation Screw: A Case Report

Thumbnail

D3.246 - A Novel Mutation in a Case of Deficiency of Interleukin-1 Receptor Antagonist in a Filipino Male Child

Thumbnail

D3.247 - Skin Involvement Is One Of The Common Signs In Children With Inborn Errors Of Immunity

Thumbnail

D3.248 - Prospective Evaluation Of The Efficacy Of Janus Kinase Inhibitor Therapy In Children With Alopecia Areata And Atopic Dermatitis

Thumbnail

D3.250 - Changes in eating behavior in children with psoriasis during biological therapy depending on epicardial adipose tissue thickness

Thumbnail

D3.251 - Prevention of Irritant Contact Dermatitis Among Dental Students

Thumbnail

D3.252 - Water-induced localized urticaria: A rare case of aquagenic urticaria

Thumbnail

D3.253 - Two Infant Cases Diagnosed with Bullous Mastocytosis, a Rare Variant of Diffuse Cutaneous Mastocytosis

Thumbnail

D3.418 - A Phase 1b Study of Lesigercept, a Long-acting High-affinity IgETrap-Fc Fusion Protein: Safety, Tolerability, PK, and PD in Atopic Healthy and Allergic Subjects

Thumbnail

D3.419 - Efficacy, safety, and remission outcomes of omalizumab in elderly patients with severe allergic asthma: a subgroup analysis by age of onset

Thumbnail

D3.420 - Real-world epidemiologic characteristics of patients treated with dupilumab for type 2 inflammatory indications: a single-center retrospective cohort study

Thumbnail

D3.421 - Real-world Effectiveness and Safety of Lanadelumab Treatment in Patients With Hereditary Angioedema: The 12-Month Interim Analysis of a Polish, Prospective, Multicenter, Observational Study (CHOPIN)

Thumbnail

D3.422 - Dupilumab in children with multimorbid atopic phenotype: therapy efficacy, safety and biomarker changes

Thumbnail

D3.423 - Lanadelumab treatment is effective and safe in patients with Factor XII associated cold-induced autoinflammatory syndrome: results from an open-label proof-of-concept study

Thumbnail

D3.424 - Retrospective Analysis of Self-Administration of Biologic Treatments for Severe Asthma and Chronic Urticaria